REQUEST A DEMO
Total
USD $0.00
Search more companies

Apple Formulations Private Limited. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Apple Formulations Private Limited. Profile Updated: June 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Apple Formulations Private Limited. is an unlisted company, incorporated on 06/05/2006. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24121DL2006PTC148648 and registration number is 148648.

Headquarters
Flat No. 24 - C 2Nd Floor Pocket - B Sector East Delhi In-Dl In 110096
East Delhi; Delhi; Postal Code: 110096

Contact Details: Purchase the Apple Formulations Private Limited. report to view the information.

Basic Information
Total Employees:
Purchase the Apple Formulations Private Limited. report to view the information.
Outstanding Shares:
Purchase the Apple Formulations Private Limited. report to view the information.
Registered Capital:
Purchase the Apple Formulations Private Limited. report to view the information.
Incorporation Date:
May 06, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Apple Formulations Private Limited. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
31.68%
Total operating revenue
31.82%
Operating profit (EBIT)
29.91%
EBITDA
15.93%
Net Profit (Loss) for the Period
31.35%
Total assets
45.63%
Total equity
26.97%
Operating Profit Margin (ROS)
-0.04%
Net Profit Margin
0%
Return on Equity (ROE)
0.7%
Debt to Equity Ratio
30.59%
Quick Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?